Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Is Grupo Financero Sntdr Mxco SAB de CV ADR (BSMX) A Good Stock To Buy?

Page 1 of 2

Reputable billionaire investors such as Nelson Peltz and David Tepper generate exorbitant profits for their wealthy accredited investors (a minimum of $1 million in investable assets would be required to invest in a hedge fund and most successful hedge funds won’t accept your savings unless you commit at least $5 million) by pinpointing winning small-cap stocks. There is little or no publicly-available information at all on small companies, which makes it hard for an individual investor to pin down a ‘winner’ within the small-cap collection of stocks. However, hedge funds and other big asset managers can do the due diligence and analysis for you instead, thanks to their highly-skilled research teams and unlimited resources to conduct an appropriate evaluation process. Looking for potential winners within the small-cap galaxy of stocks? We believe following the smart money is a good starting point.

Grupo Financero Sntdr Mxco SAB de CV ADR (NYSE:BSMX) investors should pay attention to an increase in support from the world’s most elite money managers lately. BSMX was in 10 hedge funds’ portfolios at the end of the third quarter of 2015. There were 9 hedge funds in our database with BSMX positions at the end of the previous quarter. At the end of this article we will also compare BSMX to other stocks, including Bunge Ltd (NYSE:BG), American Water Works Co., Inc. (NYSE:AWK), and Lennar Corporation (NYSE:LEN) to get a better sense of its popularity.

To most investors, hedge funds are assumed to be unimportant, outdated financial vehicles of years past. While there are over 8000 funds with their doors open today, our researchers hone in on the crème de la crème of this group, about 700 funds. Most estimates calculate that this group of people administer bulk of the hedge fund industry’s total asset base, and by shadowing their matchless stock picks, Insider Monkey has uncovered several investment strategies that have historically surpassed the market. Insider Monkey’s small-cap hedge fund strategy outpaced the S&P 500 index by 12 percentage points annually for a decade in their back tests.

Now, we’re going to take a look at the key action regarding Grupo Financero Sntdr Mxco SAB de CV ADR (NYSE:BSMX).

Hedge fund activity in Grupo Financero Sntdr Mxco SAB de CV ADR (NYSE:BSMX)

At Q3’s end, a total of 10 of the hedge funds tracked by Insider Monkey were bullish on this stock, a change of 11% from the previous quarter. With hedgies’ sentiment swirling, there exists a select group of key hedge fund managers who were upping their holdings considerably (or already accumulated large positions).

Of the funds tracked by Insider Monkey, Indus Capital, managed by David Kowitz and Sheldon Kasowitz, holds the most valuable position in Grupo Financero Sntdr Mxco SAB de CV ADR (NYSE:BSMX). Indus Capital has a $10.6 million position in the stock, comprising 1.4% of its 13F portfolio. Coming in second is Renaissance Technologies, managed by Jim Simons, which holds a $2.1 million position; less than 0.1%% of its 13F portfolio is allocated to the stock. Remaining hedge funds and institutional investors that hold long positions encompass David Halpert’s Prince Street Capital Management, Israel Englander’s Millennium Management and Andre F. Perold’s HighVista Strategies.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!